Claims
- 1. A method for producing therapeutic compounds comprising the steps of:
using as a substrate a first chemical composition represented by the following structure: 1wherein R is selected from a group consisting of CH3, CH2CH3, and CH2C6H5; and through a substitution reaction, producing from said first chemical composition a second chemical composition represented by the following structural formula: 2wherein R1 is selected from a group consisting of OCH3, OCH2CH3, OCH2C6H5 AND CH2CH3.
- 2. The method of claim 1 further comprising the step of producing from said second chemical composition a third chemical composition represented by the following structural formula:
- 3. A method of inducing apoptosis in cancerous tissues which are characterized as reactive to therapeutic doses of 2-Methoxyestradiol, comprising, in lieu of, or in combination with administering such doses of 2-Methoxyestradiol, the steps of:
selecting a chemical composition represented by the following structural formula: 4wherein R1 is selected from a group consisting of OCH3, OCH2CH3, OCH2C6H5 AND CH2CH3; and administering a therapeutic dose of said chemical composition to said cancerous cells.
- 4. A method of inducing apoptosis in cancerous tissues which are characterized as reactive to therapeutic doses of 2-Methoxyestradiol, comprising, in lieu of, or in combination with administering such doses of 2-Methoxyestradiol, the steps of:
selecting a chemical composition represented by the following structural formula: 5wherein R1 is selected from a group consisting of OCH3, OCH2CH3, OCH2C6H5 AND CH2CH3; and administering a therapeutic dose of said first chemical composition to said cancerous cells.
- 5. A method of inducing apoptosis in cancerous tissues which are characterized as reactive to therapeutic doses of 2-Methoxyestradiol, comprising, in lieu of, or in combination with administering such doses of 2-Methoxyestradiol, the steps of:
selecting a chemical composition represented by the following structural formula: 6and administering a therapeutic dose of said chemical composition to said cancerous cells.
- 6. A method of inducing apoptosis in cancerous tissues which are characterized as reactive to therapeutic doses of 2-Methoxyestradiol, comprising, in lieu of, or in combination with administering such doses of 2-Methoxyestradiol, the steps of:
selecting a chemical composition represented by the following structural formula: selecting a chemical composition represented by the following structural formula: 7and administering a therapeutic dose of said chemical composition to said cancerous cells.
- 7. A method of inducing apoptosis in cancerous tissues which are characterized as reactive to therapeutic doses of 2-Methoxyestradiol, comprising, in lieu of, or in combination with administering such doses of 2-Methoxyestradiol, the steps of:
selecting a chemical composition represented by the following structural formula: 8and administering a therapeutic dose of said chemical composition to said cancerous cells.
CITATION TO PRIOR APPLICATION
[0001] This is a continuation application in respect of U.S. application Ser. No. 09/777,151, filed Feb. 5, 2001, which was an continuation-in-part of U.S. application Ser. No. 527283, filed Mar. 17, 2000 from which, as applicable, priority is claimed under 35 U.S.C. § 120 and under provisions of the Patent Cooperation Treaty.
Continuations (1)
|
Number |
Date |
Country |
Parent |
09777151 |
Feb 2001 |
US |
Child |
10603571 |
Jun 2003 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09527283 |
Mar 2000 |
US |
Child |
09777151 |
Feb 2001 |
US |